{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T13:31:18Z","timestamp":1789651878428,"version":"4.0.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"UK Ministry of Defence"}],"content-domain":{"domain":["clinicalkey.jp","ijaaonline.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.ijantimicag.2017.08.006","type":"journal-article","created":{"date-parts":[[2017,8,9]],"date-time":"2017-08-09T18:15:35Z","timestamp":1502302535000},"page":"806-808","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Use of axenic media to determine antibiotic efficacy against coxiella burnetii"],"prefix":"10.1016","volume":"51","author":[{"given":"K.A.","family":"Clay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.G.","family":"Hartley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.H.","family":"Norville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2017.08.006_bib0010","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/ije\/22.5.945","article-title":"Q fever is absent from New Zealand","volume":"22","author":"Hilbink","year":"1993","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.ijantimicag.2017.08.006_bib0015","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/1471-2334-14-255","article-title":"Absence of antibodies to Rickettsia spp., Bartonella spp., Ehrlichia spp. and Coxiella burnetii in Tahiti, French Polynesia","volume":"14","author":"Musso","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.08.006_bib0020","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/1471-2334-12-280","article-title":"Assessing the long-term health impact of Q-fever in the Netherlands: a prospective cohort study started in 2007 on the largest documented Q-fever outbreak to date","volume":"12","author":"van Loenhout","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.08.006_bib0025","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1128\/CMR.00045-16","article-title":"From Q fever to Coxiella burnetii infection: a paradigm change","volume":"30","author":"Eldin","year":"2017","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2017.08.006_bib0030","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/imj.1962.11.3.184","article-title":"Tetracycline in the treatment of \u2018Q\u2019 fever","volume":"11","author":"Powell","year":"1962","journal-title":"Australas Ann Med"},{"key":"10.1016\/j.ijantimicag.2017.08.006_bib0035","doi-asserted-by":"crossref","first-page":"6939","DOI":"10.1128\/JB.01856-12","article-title":"Genome sequence of Coxiella burnetii 109, a doxycycline-resistant clinical isolate","volume":"194","author":"Rouli","year":"2012","journal-title":"J Bacteriol"},{"key":"10.1016\/j.ijantimicag.2017.08.006_bib0040","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1586\/14787210.2013.840534","article-title":"Antimicrobial therapies for Q fever","volume":"11","author":"Kersh","year":"2013","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.ijantimicag.2017.08.006_bib0045","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1017\/S0950268810002621","article-title":"Antibiotic therapy for acute Q fever in The Netherlands in 2007 and 2008 and its relation to hospitalization","volume":"139","author":"Dijkstra","year":"2010","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.ijantimicag.2017.08.006_bib0050","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/cid\/ciu259","article-title":"Reevaluation of the risk of fetal death and malformation after Q fever","volume":"59","author":"Million","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.08.006_bib0055","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1128\/AAC.42.10.2747","article-title":"In vitro susceptibility of Coxiella burnetii to trovafloxacin in comparison with susceptibilities to pefloxacin, ciprofloxacin, ofloxacin, doxycycline, and clarithromycin","volume":"42","author":"Gikas","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.08.006_bib0060","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ijantimicag.2004.05.001","article-title":"In vitro susceptibility of Coxiella burnetii to azithromycin, doxycycline, ciprofloxacin and a range of newer fluoroquinolones","volume":"24","author":"Lever","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2017.08.006_bib0065","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1128\/AEM.02826-10","article-title":"Isolation from animal tissue and genetic transformation of Coxiella burnetii are facilitated by an improved axenic growth medium","volume":"77","author":"Omsland","year":"2011","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.ijantimicag.2017.08.006_bib0070","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1086\/647952","article-title":"Antimicrobial susceptibility testing: a review of general principles and contemporary practices","volume":"49","author":"Jorgensen","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.08.006_bib0075","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1128\/IAI.32.2.840-851.1981","article-title":"Immunological and biological characterization of Coxiella burnetii, phases I and II, separated from host components","volume":"32","author":"Williams","year":"1981","journal-title":"Infect Immun"},{"key":"10.1016\/j.ijantimicag.2017.08.006_bib0080","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nrmicro862","article-title":"Antimicrobial pharmacodynamics: critical interactions of \u2018bug and drug\u2019","volume":"2","author":"Drusano","year":"2004","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ijantimicag.2017.08.006_bib0085","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijantimicag.2003.07.007","article-title":"Measurement of the antibiotic susceptibility of Coxiella burnetii using real time PCR","volume":"23","author":"Boulos","year":"2004","journal-title":"Int J Antimicrob Agents"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857917302984?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857917302984?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T17:00:10Z","timestamp":1602694810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857917302984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0924857917302984"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.08.006","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of axenic media to determine antibiotic efficacy against coxiella burnetii","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}